✦ LIBER ✦

Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial

✍ Scribed by Deepak L. Bhatt; Marcus D. Flather; Werner Hacke; Peter B. Berger; Henry R. Black; William E. Boden; Patrice Cacoub; Eric A. Cohen; Mark A. Creager; J. Donald Easton; Christian W. Hamm; Graeme J. Hankey; S. Claiborne Johnston; Koon-Hou Mak; Jean-Louis Mas; Gilles Montalescot; Thomas A. Pearson; P. Gabriel Steg; Steven R. Steinhubl; Michael A. Weber; Liz Fabry-Ribaudo; Tingfei Hu; Eric J. Topol; Keith A.A. Fox

Book ID: 119266699
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 534 KB
Volume: 49
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2007.03.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patients with Peripheral Arterial Diseas

Patients with Peripheral Arterial Disease in the CHARISMA Trial

✍ P.P. Cacoub; D.L. Bhatt; P.G. Steg 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Effect of beta blockers on incidence of

Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease

✍ Wilbert S Aronow; Chul Ahn 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Incidence of New Stroke or New Myocardia

Incidence of New Stroke or New Myocardial Infarction or Death in Patients With Severe Carotid Arterial Disease Treated With and Without Statins

✍ Gautham Ravipati; Wilbert S. Aronow; Chul Ahn; Venu Channamsetty; Vishal Sekhri 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Macrophage migration inhibitory factor a

Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: The EPIC-Norfolk Prospective Population study

✍ S. Matthijs Boekholdt; Ron J.G. Peters; Nicholas E. Day; Robert Luben; Sheila A. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 102 KB

PCV30 CLOPIDOGREL IS COST-EFFECTIVE COMP

PCV30 CLOPIDOGREL IS COST-EFFECTIVE COMPARED WITH ASPIRIN IN UNITED KINGDOM PATIENTS WITH A MYOCARDIAL INFARCTION WHO SUBSEQUENTLY SUSTAIN AN ISCHAEMIC STROKE OR PERIPHERAL ARTERIAL DISEASE EVENT

✍ MD Stevenson; AC Rawdin; JD Karnon; A Brennan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Comparison of Usefulness of Inflammatory

Comparison of Usefulness of Inflammatory Markers in Patients With Versus Without Peripheral Arterial Disease in Predicting Adverse Cardiovascular Outcomes (Myocardial Infarction, Stroke, and Death)

✍ Joshua A. Beckman; Ori Preis; Paul M. Ridker; Marie Gerhard-Herman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB